AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01755143 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pacemaker System
Study NCT04115592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cocoa butter oleogel
Description: Consumption of cocoa butter oleogel made with chocolate confectionery
Study NCT04115592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sal seed oil
Description: Consumption of sal seed oil made with chocolate confectionery
Study NCT04115592 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sal seed oleogel
Description: Consumption of sal seed oleogel made with chocolate confectionery
Study NCT01911481 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hydration
Study NCT02557802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluenz Tetra
Description: Intranasal spray, 0.2 ml dose
Study NCT02557802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fluarix Tetra
Description: Intramuscular injection, 0.5 ml dose
Study NCT01415817 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training session
Description: Series of two training sessions after the first phase of study followed by monthly feedback.
Study NCT00895622 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 54 Gy radiotherapy
Description: External beam radiation therapy (EBRT) to a total dose of 54 Gy (RBE) in 30 fractions. 1.8 Gy (RBE) daily, 5 fractions per week, excluding weekends. 3D-CRT or IMRT or Proton allowed.
Study NCT00895622 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 60 Gy radiotherapy
Description: External beam radiation therapy using intensity-modulated radiation therapy (IMRT) to a total dose of 60 Gy in 30 fractions. 2.0 Gy daily, 5 fractions per week, excluding weekends.
Study NCT00377286 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Glucosamine (a dietary supplement)
Description: 1500 mg in 16 oz lite lemonade, once per day for 6 months
Study NCT00926848 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Partners Together in Health (PaTH) Intervention
Description: Patients and partners in the PaTH experimental group participated in 18-36 exercise and 18 educational sessions in a structured cardiac rehabilitation program. Patients in the Usual care group also participated in 18-36 exercise and 18 educational sessions; partners, however, only participated in the educational sessions.
Study NCT00926848 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Partners Together in Health (PaTH) Intervention
Description: Patients and partners in the PaTH experimental group participated in 18-36 exercise and 18 educational sessions in a structured cardiac rehabilitation program. Patients in the Usual care group also participated in 18-36 exercise and 18 educational sessions; partners, however, only participated in the educational sessions.
Study NCT01730027 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ADC3680
Description: ADC3680 for 12 weeks plus montelukast for the last 2 weeks of the dosing period
Study NCT01730027 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo for 12 weeks plus montelukast for the last 2 weeks of the dosing period
Study NCT01730027 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: montelukast
Description: montelukast for 12 weeks
Study NCT01335048 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atorvastatin and clopidogrel
Description: Atorvastatin 80 mg daily + clopidogrel 150 mg daily
Study NCT01335048 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clopidogrel
Description: Clopidogrel 150 mg daily
Study NCT03619239 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GX-I7
Description: During Treatment Period, patients will receive the assigned dose of GX-I7 intramuscular injection every 4\~12 weeks per cycle up to 6 cycles in the absence of unacceptable toxicity or clinically compelling evidence of disease progression.
Study NCT02932527 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire about cannabis consumption
Description: Questionnaire about cannabis consumption will be assessed to infertile male exposed to cannabis and infertile male not exposed to cannabis.
Study NCT02932527 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Questionnaire about cannabis consumption
Description: Questionnaire about cannabis consumption will be assessed to infertile male exposed to cannabis and infertile male not exposed to cannabis.
Study NCT02932527 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: blood intake
Description: blood intake is done for infertile male exposed and infertile male not exposed.
Study NCT02932527 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: blood intake
Description: blood intake is done for infertile male exposed and infertile male not exposed.
Study NCT02932527 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Semen samples collection
Description: Semen samples are collected for infertile male exposed and infertile male not exposed.
Study NCT02932527 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Semen samples collection
Description: Semen samples are collected for infertile male exposed and infertile male not exposed.
Study NCT04428476 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Deramiocel (CAP-1002)
Description: Peripheral infusion of 150 million allogeneic cardiosphere-derived cells administered every three months
Study NCT01490073 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insertion of nitroglycerin ointment
Description: Nitroglycerin ointment inserted into the vagina 30-45 minutes prior to IUD insertion
Study NCT01490073 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Insertion of placebo ointment
Description: Placebo ointment inserted into the vagina 30-45 minutes prior to IUD insertion
Study NCT02235077 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spironolactone
Description: Patients receiving no MRA at home will receive spironolactone 100 mg (4x25 mg capsules) once daily for 96 hours.~Patients already receiving low-dose MRA at home will be randomized to receive spironolactone 25 mg (1x25 mg capsules) or 100 mg (4x25 mg capsules) in hospital for 96 hours. The patients who are randomized to 25 mg spironolactone will also receive 75 mg placebo (3x25 mg capsules) in order to maintain blinding.
Study NCT02235077 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients receiving no MRA at home will receive 100 mg placebo (4x25 mg capsules) once daily for 96 hours.~Patients who are randomized to 25 mg spironolactone will also receive 75 mg placebo (3x25 mg capsules) in order to maintain blinding.
Study NCT01682226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CliniMACS Fractionation system (Arm A)
Description: 7 days before transplant Admit to hospital. Line insertion 6 days before transplant Fludarabine (chemotherapy) Cyclophosphamide (chemotherapy) 5 days before transplant Fludarabine Thiotepa 4 days before transplant Fludarabine Thiotepa 3 days before transplant Fludarabine Start CSA and MMF 2 days before transplant Fludarabine and TBI (radiation therapy)~1 day before transplant TBI (radiation therapy) Day of transplant Transplant day (infuse cord blood) Day after cord blood transplant Infuse family member stem cells 7 days after transplant Start G-CSF
Study NCT01682226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CliniMACS Fractionation system (Arm B)
Description: 8 days before transplant Admit to hospital. Line insertion 7 days before transplant Fludarabine 6 days before transplant Fludarabine Cyclophosphamide 5 days before transplant Fludarabine Cyclophosphamide 4 days before transplant Rest 3 days before transplant TBI x 3 Start CSA and MMF 2 days before transplant TBI x 3~1 day before transplant TBI x 3 Day of transplant TBI x 2 then infuse cord blood~1 day after the cord blood transplant Infuse family member stem cells 7 days after transplant Start G-CSF
Study NCT01682226 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Haploidentical donor CD34+ cells
Description: CB grafts will consist of two CB units 4-6/6 HLA-matched to the patient to augment graft cell dose and additional T-cell depleted PBSC from a haplo-identical donor.
Study NCT02036840 — intervention group
Intervention type: DRUG
Intervention: Antibiotic
Study NCT05364281 — intervention group
Intervention type: OTHER
Intervention: Intracuff pressure measurement
Description: The intracuff pressures were measured and noted after each position (neck extension and placement of mouth gag), at every 5th minute while the operation and before the extubating.
Study NCT00930774 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: FM system
Description: Frequency modulation assistive device
Study NCT00930774 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auditory training
Description: Participation in computerized auditory training program for eight weeks
Study NCT00377286 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 16 oz lite lemonade
Description: 16 oz lite lemonade 1 time daily for 6 months
Study NCT02468635 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: upper limb exercises
Description: HEATING PHASE: diagonals for upper and lower limbs (5-10 minutes). AEROBIC PHASE: aerobic exercise on a treadmill or bicycle between 5 - 30 minutes and rest 1-2 minutes according to the Borg scale and patient tolerance (Borg scores for dyspnea 4-5); RESISTANCE STAGE: upper limb exercises with weight training equipment or dumbbells (the patient's adaptation) with 50% of maximum load reached the maximum repetition test. Series 2 minutes and rest interval between sets 1-2 minutes. RESPIRATORY TRAINING : Strengthening of the respiratory muscles 5-15 minutes with Threshold with load of 50% of the affected MIP (measure maximal inspiratory pressure) evaluation. RELAXATION: Stretching and muscle massage therapy group involved in the 5-10 minute workout.
Study NCT04176315 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Home-based Rehabilitation Plan
Description: Usual intervention at Presidio Sanitario San Camillo for post-operative rehabilitation of THA patients. Participants receive inpatient care and rehabilitation for 2 weeks. At discharge, they receive a 5-exercise home-based rehabilitation plan. For the sake of homogeneity of all participants, they receive from 2 to 4 of training prior to discharge. At home, participants shall perform the exercises in the rehabilitation plan daily.
Study NCT02468635 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: without training for upper limb
Description: HEATING PHASE: diagonals for upper and lower limbs (5-10 minutes). AEROBIC PHASE: aerobic exercise on a treadmill or bicycle between 5 - 30 minutes and rest 1-2 minutes according to the Borg scale and patient tolerance (Borg scores for dyspnea 4-5); RESPIRATORY TRAINING: Strengthening respiratory muscles 5-15 minutes with Threshold with load of 50% of MIP hit in the evaluation. RELAXATION: Stretching and muscle massage therapy group involved in the 5-10 minute workout.
Study NCT03621202 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Saranas Early Bird Bleed Monitoring System (EBBMS)
Description: Participants will undergo their planned endovascular procedure with monitoring for internal bleeding using the Saranas EBBMS.
Study NCT04129814 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non surgical periodontal therapy
Description: single session full-mouth scaling and root planing
Study NCT01406522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral tacrine
Description: Tacrine, 160 mg per day, four times daily
Study NCT04176315 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ReHub Home-based Rehabilitation Plan
Description: Combination of the usual intervention at Presidio Sanitario San Camillo for post-operative rehabilitation of THA patients with ReHub, a telerehabilitation platform that serves as a guide to perform the TKA rehabilitation exercises.~Participants receive inpatient care and rehabilitation at San Camillo for 2 weeks. At discharge, a 5-exercise home-based rehabilitation plan is carried out by a site physiotherapist by using ReHub to acquire the participant's movement pattern with a wearable inertial sensor. Participants receive from 2 to 4 sessions of ReHub prior to discharge.~At home, participants shall perform the exercises in the rehabilitation plan with ReHub daily. The wearable inertial sensor participants must wear tracks movement while they do the TKA rehabilitation exercises. Movement is analysed and feedback is given in real time. Participants can select if they have felt pain in a scale from 1 to 10. A physiotherapist monitors the participants' progress remotely.
Study NCT01406522 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral placebo
Description: Microcrystalline cellulose
Study NCT04369001 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community-Based Exercise
Description: Participants will complete 150 minutes of exercise per week for 12 weeks. Exercise per week will be documented using exercise logs. The exercise protocol will be a culturally-tailored community-based exercise intervention based on the aerobic exercise goals used in the Program ACTIVE study and psychoeducational materials adapted from Program ACTIVE based on feedback from Black men with T2D. Exercise in Program ACTIVE will be obtained through individualized community-based activities that participants in the focus groups indicate as feasible rather than the highly controlled laboratory environment. Exercise goals will be adapted to accommodate the physical and medical restrictions of an older-adult diabetes population.
Study NCT04369001 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy
Description: Participants will receive 10 sessions of CBT using a manualized approach based on Beck's model of cognitive therapy. Sessions are to be completed once weekly in conjunction with weekly exercise. The Program ACTIVE CBT intervention includes: presentation of CBT model; thought records, cognitive distortions, counterarguments, cognitive reframing, automatic thoughts, core beliefs, and relapse prevention. Session goals will be tailored to the needs of men so that the order of topics may vary. Each session will begin with the designation of session goals, review of previously assigned homework, and introduction of new concepts and skills. Individually-tailored homework assignments designed to provide practice with the concepts/skills of the session will be assigned.
Study NCT00743561 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Polysomnography
Description: Simultaneous recording of electro-encephalography, tibial and submental electro-myography, electro-oculography, nasal air flow, oxygen saturation, as well as the thoracic and abdominal respiratory effort
Study NCT00743561 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: ambulatory polygraphy
Description: Simultaneous recording of nasal air flow, oxygen saturation, as well as the abdominal and thoracic respiratory effort.
Study NCT04416698 — intervention group
Intervention type: BEHAVIORAL
Intervention: Individual qualitative interview
Description: Individual interviews will be conducted to understanding the needs and concerns of youth smokers of e-cigarette or other new tobacco products, including their risk perceptions, and the behaviour, attitudes, and experiences related to these tobacco products.
Study NCT04416698 — intervention group
Intervention type: BEHAVIORAL
Intervention: cross-sectional survey study
Description: structured questionnaire will be constructed for a cross-sectional survey to further explore the behaviour, attitudes, and experiences related to electronic cigarettes or other new tobacco products among youth.
Study NCT03507322 — intervention group
Intervention type: OTHER
Intervention: Ultrasound texturization
Description: Along several visits to the clinic, the patients will be subjected to 2D/3D ultrasound scanning.
Study NCT03391570 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: COX-2 inhibitor
Description: Celebrex 200mg/1cap 2 tablets, take medication an hour before surgery
Study NCT03391570 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Ramnos 250mg/1cap 2 tablets, take medication an hour before surgery
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Preoperative peritoneal biopsy
Description: Preoperative peritoneal biopsy (1x1cm sized peritoneal tissue)
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Preoperative peritoneal biopsy
Description: Preoperative peritoneal biopsy (1x1cm sized peritoneal tissue)
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Single-port laparoscopic surgery
Description: Single-port laparoscopic surgery with CO2 gas
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Single-port laparoscopic surgery
Description: Single-port laparoscopic surgery with CO2 gas
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Postoperative peritoneal biopsy
Description: Postoperative peritoneal biopsy (1x1cm sized peritoneal tissue)
Study NCT03391570 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Postoperative peritoneal biopsy
Description: Postoperative peritoneal biopsy (1x1cm sized peritoneal tissue)
Study NCT00886639 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 6MWT with oxygen
Description: 2 liter per minute as continuous-flow
Study NCT00886639 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: 6MWT with medical air
Description: 2 liters as continuous-flow
Study NCT01058317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol
Description: Propranolol 2mg/kg divided twice daily
Study NCT01928134 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vit K2+ Vit D3+ calcium carbonate (CaCO3)
Study NCT01928134 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vit K2+CaCO3
Study NCT02168764 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ATI Neurostimulation System
Description: All subjects will be implanted with the ATI Neurostimulator which, along with the ATI Remote Controller, provides electrical stimulation.
Study NCT02168764 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ATI Neurostimulation System
Description: All subjects will be implanted with the ATI Neurostimulator which, along with the ATI Remote Controller, provides electrical stimulation.
Study NCT00051168 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Travatan
Description: Travoprost (0.004%) 1 drop each eye once daily
Study NCT03243162 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBPT-ACLR
Description: The CBPT-ACLR program focuses on improving sports function and return to sport. CBPT-ACLR sessions cover realistic expectations, relaxation strategies, problem-solving training, cognitive restructuring, and behavioral self-management (i.e., graded activity, goal setting, managing setbacks and symptom management plans). Each session builds upon the content of the previous session using an action plan and weekly homework is personally tailored based on patient goals. The program consists of one preoperative telephone session and six postoperative telephone sessions with a physical therapist. Each patient randomized into the CBPT-ACLR program will receive a manual to follow along with the study therapist.
Study NCT03243162 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Education
Description: The education program focuses on postoperative ACLR recovery. Sessions address benefits of physical therapy, proper biomechanics during sports and other functional activity, importance of early exercise after surgery, and ways to promote healing. Education on stress reduction, sleep hygiene, energy management, communication with health providers, and preventing future injury are also provided. The Education program is matched to the CBPT-ACLR treatment in terms of session frequency, length and contact with the study therapist. Each patient randomized into the Education program will receive a manual to follow along with the study therapist.
Study NCT05166525 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medically tailored meals
Description: Compare medically tailored meals vs. medically tailored meals with enhanced nutritional counseling vs. usual care
Study NCT05166525 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Medically tailored meals
Description: Compare medically tailored meals vs. medically tailored meals with enhanced nutritional counseling vs. usual care
Study NCT04036461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-99712
Description: CC-99712
Study NCT04036461 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986405
Description: BMS-986405
Study NCT01736059 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CD34+ bone marrow stem cells intravitreal
Study NCT04429087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 764532 - parenteral 1
Description: BI 764532 - parenteral 1
Study NCT04429087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 764532 - parenteral 2
Description: BI 764532 - parenteral 2
Study NCT00256503 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy for Insomnia
Description: Insomnia Subjects receive CBT-I
Study NCT03340948 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR)
Description: An 8-week course in mindfulness meditation, yoga training and weekly group support in the form of weekly 2,5 hour meetings at the hospital.
Study NCT03315130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: zilucoplan (RA101495)
Description: Daily subcutaneous (SC) injection